Vascular endothelial growth factor (VEGF-A) is a major pathogenic factor and a therapeutic target for age-related macular degeneration, diabetic retinopathy, and retinopathy of prematurity. Despite intensive effort in the field, the cellular mechanisms of VEGF action remain virtually uninvestigated. This situation makes it difficult to design cellular target-based therapeutics for these diseases. In light of the recent finding that VEGF is a potential neurotrophic factor, revealing the cellular mechanisms of VEGF action becomes necessary to preserve its beneficial effect and inhibit its pathological function in long-term anti-VEGF therapeutics for ocular vascular diseases. We therefore generated conditional VEGF knockout mice with an inducible Cre/lox system and determined the significance of Müller cell-derived VEGF in retinal development and maintenance and ischaemia-induced neovascularizartion and vascular leakage. Retinal development in the conditional VEGF knockout mice was analysed by examining retinal and choroidal vasculatures and retinal morphology and function. Ischaemia-induced retinal neovascularization and vascular leakage in the conditional VEGF knockout mice were analysed with fluorescein angiography, quantification of proliferative neovascular cells, immunohistochemistry, and immunoblotting using an oxygen-induced retinopathy model. Our results demonstrated that disruption of Müller cell-derived VEGF resulted in no apparent defects in retinal and choroidal vasculatures and retinal morphology and function, significant inhibition of the ischaemia-induced retinal neovascularization and vascular leakage, and attenuation of the ischaemia-induced breakdown of the blood-retina barrier. These results suggest that the retinal Müller cell-derived VEGF is a major contributor to ischaemia-induced retinal vascular leakage and pre-retinal and intra-retinal neovascularization. The observation that a significant, but not complete, reduction of VEGF in the retina does not cause detectable retinal degeneration suggests that appropriate doses of anti-VEGF agents may be important to the safe treatment of retinal vascular diseases.

Hydrometallation of alkenes and alkynes provides a straightforward route to access alkyl-or alkenyl-metal reagents, which have a wide range of applications in organic transformations. In recent years, the first row transition metals (such as copper, nickel, cobalt, iron, etc.) have emerged high activity and selectivity in this area with the aid of a variety of ligands. This review covers the recent advances in the hydrometallation of minimally functionalized unsaturated C-C bonds (including alkenes, alkynes, dienes, allenes, enynes, etc.), as well as transformations involving catalytic hydrometallation process via the first row transition metal catalysis.

These data indicate that the Ins2(Akita) mouse is a good model for later-onset DR, modeling both early and some late disease signs. Furthermore, this work suggests that this model may be suitable for testing and development of targeted DR therapies.

Gene therapy is a critical tool for the treatment of monogenic retinal diseases. However, the limited vector capacity of the current benchmark delivery strategy, adeno-associated virus (AAV), makes development of larger capacity alternatives, such as compacted DNA nanoparticles (NPs), critical. Here we conduct a side-by-side comparison of self-complementary AAV and CK30PEG NPs using matched ITR plasmids. We report that although AAVs are more efficient per vector genome (vg) than NPs, NPs can drive gene expression on a comparable scale and longevity to AAV. We show that subretinally injected NPs do not leave the eye while some of the AAV-injected animals exhibited vector DNA and GFP expression in the visual pathways of the brain from PI-60 onward. As a result, these NPs have the potential to become a successful alternative for ocular gene therapy, especially for the multitude of genes too large for AAV vectors.

No abstract

A highly regio- and enantioselective cobalt-catalyzed hydroboration/hydrogenation of internal alkynes with HBpin and a hydrogen balloon in one pot was developed. A new type of chiral imidazoline iminopyridine (IIP) ligand was introduced for the first time in this novel and efficient strategy. This protocol used relatively simple and available starting materials with good functional group tolerance to construct more valuable chiral secondary organoboronates. The primary mechanistic studies illustrated that the cobalt-catalyzed regioselective hydroboration of alkynes did initially occur followed by HBpin-promoted and cobalt-catalyzed enantioselective hydrogenation of alkenylboronates.

Recent years have witnessed the growing interest in the remote functionalization of alkenes for it offers a strategy to activate the challenging C–H bonds distant from the initiation point via alkene isomerization/functionalization. However, the catalytic enantioselective isomerization/functionalization with one single transition metal catalyst remains rare. Here we report a highly regio- and enantioselective cobalt-catalyzed remote C–H bond borylation of internal alkenes via sequential alkene isomerization/hydroboration. A chiral ligand featured twisted pincer, anionic, and non-rigid characters is designed and used for this transformation. This methodology, which is operationally simple using low catalyst loading without additional activator, shows excellent enantioselectivity and can be used to convert various internal alkenes with regio- and stereoisomers to valuable chiral secondary organoboronates with good functional group tolerance.

Conspectus Transition metal catalyzed asymmetric hydrofunctionalization of readily available unsaturated hydrocarbons presents one of the most straightforward and atom-economic protocols to access valuable optically active products. For decades, noble transition metal catalysts have laid the cornerstone in this field, on account of their superior reactivity and selectivity. In recent years, from an economical and sustainable standpoint, first-row, earth-abundant transition metals have received considerable attention, due to their high natural reserves, affordable costs, and low toxicity. Meanwhile, the earth-abundant metal catalyzed hydrofunctionalization reactions have also gained much interest and been investigated gradually. However, since chiral ligand libraries for earth-abundant transition-metal catalysis are limited to date, the development of highly enantioselective versions remains a significant challenge. This Account summarizes our recent efforts in developing suitable chiral ligands for iron and cobalt catalysts and their applications in the highly enantioselective hydrofunctionalization reactions (hydroboration and hydrosilylation) of alkenes and alkynes. In ligand design, we envisioned that chiral unsymmetric NNN-tridentate (UNT) ligand scaffolds could promote these enantioselective transformations with earth-abundant metals. Therefore, several types of chiral UNT ligands were designed and prepared in our laboratory, utilizing readily available natural amino acids as chiral sources. In the very beginning, chiral oxazoline iminopyridine (OIP) ligands were proposed and investigated through the rational combination of nitrogen-containing ligand scaffolds. After a systematic survey of the ligand effects, the imine moiety in the rigid OIP ligands was replaced by a conformationally more flexible amine unit, leading to the construction of reactive oxazoline aminoisopropylpyridine (OAP) ligands. Subsequently, imidazoline iminopyridine (IIP) and thiazoline iminopyridine (TIP) ligands were prepared by altering the oxygen atom of oxazoline with nitrogen and sulfur linkers, respectively. To further expand the chiral ligand library, other tridentate ligands containing a twisted pincer, anionic, and nonrigid backbone were also designed and synthesized, including iminophenyl oxazolinyl phenylamine (IPOPA) and imidazoline phenyl picolinamide (ImPPA). The efficacy of these chiral UNT ligands for asymmetric induction in iron and cobalt catalysis has been demonstrated through asymmetric hydrofunctionalization of alkenes and asymmetric sequential hydrofunctionalization of alkynes, which exhibit excellent reactivity as well as high chemo-, regio-, and stereoselectivity with broad functional group tolerance. Notably, highly regio- and enantioselective hydrofunctionalization of challenging substrates, such as 1,1-disubstituted aryl alkenes and terminal aliphatic alkenes, was also achieved. Furthermore, the development of asymmetric sequential isomerization/hydroboration of internal alkenes and sequential hydrofunctionaliz...